MOSUNETUZUMAB-AXGB for Diffuse large b-cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 9 adverse event reports in the FDA FAERS database where MOSUNETUZUMAB-AXGB was used for Diffuse large b-cell lymphoma.
Most Reported Side Effects for MOSUNETUZUMAB-AXGB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Cytokine release syndrome | 52 | 26.3% | 2 | 23 |
| Pyrexia | 27 | 13.6% | 0 | 16 |
| Disease progression | 25 | 12.6% | 2 | 9 |
| Off label use | 20 | 10.1% | 0 | 2 |
| Rash | 18 | 9.1% | 0 | 1 |
| No adverse event | 16 | 8.1% | 0 | 0 |
| Neutropenia | 13 | 6.6% | 1 | 1 |
| Thrombocytopenia | 9 | 4.6% | 0 | 0 |
| Chills | 8 | 4.0% | 0 | 2 |
| Fatigue | 8 | 4.0% | 0 | 3 |
| Death | 7 | 3.5% | 7 | 1 |
| Headache | 7 | 3.5% | 0 | 2 |
| Klebsiella test positive | 7 | 3.5% | 0 | 7 |
| Leukopenia | 7 | 3.5% | 0 | 0 |
| Vomiting | 7 | 3.5% | 0 | 2 |
Other Indications for MOSUNETUZUMAB-AXGB
Follicular lymphoma (126)
Product used for unknown indication (41)
Follicular lymphoma refractory (5)
Other Drugs Used for Diffuse large b-cell lymphoma
RITUXIMAB (22,275)
CYCLOPHOSPHAMIDE (16,598)
DOXORUBICIN (15,213)
VINCRISTINE (14,922)
PREDNISONE (11,266)
LENALIDOMIDE (7,858)
ETOPOSIDE (4,698)
PREDNISOLONE (4,086)
CYTARABINE (3,857)
DEXAMETHASONE (3,696)